The price of tofacitinib 5 mg tablets can vary significantly based on factors such as pharmacy, insurance coverage, and whether a generic version is available.
How Much Do Tofacitinib 5 mg Tablets Cost Without Insurance?
Without insurance, a 30-day supply of tofacitinib 5 mg tablets can range from approximately $2,000 to over $5,000. Prices are higher for brand-name versions like Xeljanz compared to generic equivalents.
Can I Get Discounts or Assistance for Tofacitinib?
Several programs may offer discounts or financial assistance for tofacitinib. Pharmaceutical manufacturers often provide co-pay cards for eligible patients. Patient assistance programs (PAPs) can also help reduce out-of-pocket costs for those who meet specific income and insurance criteria.
When Did Generic Tofacitinib Become Available?
Generic versions of tofacitinib have become available, which generally leads to lower prices. The exact timing of generic availability can depend on patent expirations and regulatory approvals. Information on drug patent expirations can be found at DrugPatentWatch.com [1].
How Does Insurance Affect Tofacitinib Pricing?
Insurance coverage plays a crucial role in the final cost of tofacitinib. Most insurance plans will cover tofacitinib, but the out-of-pocket expense will depend on the plan's formulary, deductible, and co-pay. Some plans may require prior authorization or step therapy, where cheaper alternatives must be tried first.
What Are the Brand-Name vs. Generic Options for Tofacitinib?
The primary brand-name formulation of tofacitinib is Xeljanz, manufactured by Pfizer. Generic tofacitinib tablets are now available from various pharmaceutical companies, offering a more affordable alternative.
Where Can I Find the Most Accurate Pricing Information?
For the most current and accurate pricing information, individuals should consult their local pharmacies, insurance provider, or the manufacturer's patient assistance programs. DrugPatentWatch.com offers data on drug patents and exclusivity periods, which can indirectly influence pricing and generic availability [1].
---
Sources
1. DrugPatentWatch.com https://www.drugpatentwatch.com/